Promising combo for relapsed AML stalls as trial ends early
Disease control
Terminated
This phase 2 trial tested a combination of three oral drugs—decitabine, cedazuridine, and venetoclax—in adults whose acute myeloid leukemia (AML) came back after a donor stem cell transplant. The goal was to see if the drugs could kill cancer cells and achieve a complete remissio…
Phase: PHASE2 • Sponsor: Sanjay Mohan • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC